Neuraltherapeutic Medicinal Approach to Managing Post-acute Coronavirus Disease 2019 Syndrome: Case Report

Introduction: Neuraltherapeutic Medicine (NTM), also known as Neural Therapy, is thought to exert modulatory effects on nonspecific responses through stimuli to the psychoneuroimmunoendocrine system, enhancing the system’s self-regulatory and adaptive capacities and increasing its resilience to stress that triggers specific pathophysiological events. Various studies have highlighted the potential of NTM in managing inflammatory conditions. Case Report: This case report presents the clinical course of a 37-year-old male patient treated at a Neuraltherapeutic Medicine service in a public hospital for persistent symptoms following a course of coronavirus 2019 (COVID-19) infection, diagnosed as post-acute coronavirus 2019 syndrome (PACS) based on his ongoing symptoms and a retrospective review of his medical records. The patient received four neuraltherapeutic sessions over a period of 60 days and showed satisfactory clinical improvement during a 22-month follow-up. Conclusion: This case highlights the potential role of Neuraltherapeutic Medicine in addressing persistent sequelae of COVID-19 infection. While the results are promising, further research is necessary to establish its effectiveness and safety in this patient population.